The Volumetric Pumps Market will probably reach US$ Expand Twofold between 2020 to 2030 at the rate of ~4.8%. The healthcare vertical is witnessing consolidation at a rapid pace as value-based care is on the anvil. With the majority of key participants opting for an inorganic mode of expansion, it has been observed that nearly every single business day witnesses this on paper. This riding on inorganic growth is bound to keep the healthcare vertical happening throughout.
Increasing prevalence of cancer and other chronic disorders, and rise in number surgical procedures across the globe, are expected to surge demand for volumetric pumps. Additionally, presence of a well-structured regulatory framework for using volumetric pumps in regions such as North America and Europe has been playing an important role in shaping the prospects of the global volumetric pumps market.
The COVID-19 pandemic is having a significant positive impact on the volumetric pumps market, as a result of shortage of infusion pumps to treat patients using nebulization support with rising incidence of dosing-errors cases. To overcome dosing-errors and inaccuracy in delivering drugs, surge in demand for volumetric pumps is being witnessed.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32174
Companies covered in Volumetric Pumps Market Report
- Braun Melsungen AG
- Fresenius Kabi AG
- Terumo Corporation
- ICU Medical, Inc.
- Becton, Dickinson and Company
- Smiths Medical
- Woodley Equipment Company Ltd.
- Mindray Medical International Ltd.
- ADOX S.A
- Sino-Hero (Shenzhen) Bio-Medical Electronics Co. Ltd.
- Guangzhou Huaxi Medical Science Technology Co. Ltd.
- ASCOR
- Shenzhen Shenke Medical Instrument Technical Development Co. Ltd.
- Daiwaha corp. ltd.
- CONTEC MEDICAL SYSTEMS Co. Ltd.
Request For Customization of Report @ https://www.persistencemarketresearch.com/request-customization/32174
The global volumetric pumps market is estimated to expand at a CAGR of more than 5% over the forecast period (2020-2030)
Key Takeaways from Volumetric Pumps Marker Study
- Based on product type, peristaltic pumps dominated the volumetric pumps market, owing to their advantage of lowering dose-error and delivering drugs with accurate flow rates using the peristalsis mechanism.
- The chemotherapy/ oncology segment is expected to obtain maximum revenue share over the forecast period, due to rising incidence of cancer and the treatment given in continuous cycles.
- Among all end users, the hospitals segment hold a high market revenue share, due to the availability of advanced facilities and experienced professionals across hospitals around the world.
- The COVID-19pandemic crisis is having a positive effect on the demand for volumetric pumps across the world.
“Rising incidence of dosing-error cases and inaccuracy in drug delivery are expected to shift preferences toward advanced volumetric pumps, which will propel the growth of the global volumetric pumps market over the coming years,” says a PMR analyst.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/32174
Volumetric Pumps Market: Key Strategies amongst Players
Worldwide, leading key players in the volumetric pumps market are extensively focusing on technological advancements, acquisition, and collaborations to expand their product portfolios. These key strategies are expected to propel the growth of the volumetric pumps market too. Players dealing in hospital supplies are increasingly targeting the volumetric pumps market for acquiring leading companies or those ones facing a large number of product recalls.
- For instance, in February 2015, Pfizer acquired Hospira, as the latter had been facing one of the highest product recalls in the industry, which was then acquired by ICU Medical in 2017.
- Additionally, Carefusion was acquired by Becton Dickinson, as the latter wanted to expand its market share in the surgical supplies segment.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the volumetric pumps market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030. The market has been segmented on the basis of product type (peristaltic and cassette/ piston), application (chemotherapy/ oncology, pediatrics/ neonatology, analgesia, and hematology), and end user (hospitals, ambulatory surgical centers, clinics, and others), across seven key regions.
Explore Extensive Coverage of Persistence Market Research’s Healthcare Industry
Related Reports:
Sickle Cell Disease Treatment Market:
The global sickle cell disease treatment market is projected to expand at a CAGR of 6.0 % in terms of value during the forecast period to reach US$ 584.0 Mn by 2025.
Dysphagia Diet Thickening Agents Market:
The global dysphagia diet thickening agents market was valued at US$ 415Mn in 2018, and is expected to witness a CAGR of 5% during the forecast period (2019–2029).
Spinal Cord Trauma Treatment Market:
The global spinal cord trauma treatment market is expected to expand at a CAGR of 3.7% over the forecast period to reach a value of US$ 3,036.2 Mn by 2025 end.
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com